A multicomponent reaction-based platform opens new avenues in Aryl Hydrocarbon Receptor modulation

dc.contributor.authorNadal Rodríguez, Pau
dc.contributor.authorHartung, Frederick
dc.contributor.authorPedrola Teixell, Marina
dc.contributor.authorCoomar, Seemon
dc.contributor.authorDiaz-Moreno, Alejandro
dc.contributor.authorHätälä, Anna M.
dc.contributor.authorRolfes, Katharina M.
dc.contributor.authorSánchez-Vera, Ismael
dc.contributor.authorGil, Joan
dc.contributor.authorMolins i Grau, Elies
dc.contributor.authorViayna Gaza, Antonio
dc.contributor.authorHanzl, Alexander
dc.contributor.authorThomä, Nicolas H.
dc.contributor.authorHaarmann-Stemmann, Thomas
dc.contributor.authorLuque Garriga, F. Xavier
dc.contributor.authorLavilla Grífols, Rodolfo
dc.contributor.authorGhashghaei, Ouldouz
dc.date.accessioned2025-06-23T06:58:29Z
dc.date.available2025-06-23T06:58:29Z
dc.date.issued2025-04-10
dc.date.updated2025-06-23T06:58:29Z
dc.description.abstractA multidisciplinary platform is presented to address aryl hydrocarbon receptor (AhR) modulation. A rewired Yonemitsu multicomponent reaction with indole 2-carboxaldehydes and nucleophilic species was designed to access a family of 6-substituted indolocarbazoles. The conformational behavior of these compounds was examined to rationalize their axial chirality. In silico docking and molecular simulations highlighted key features implicated in their binding to AhR. Furthermore, the synthesis of linkable derivatives allowed the direct development of conjugated entities. Reporter gene and target gene expression analyses identified these novel structures as potent noncytotoxic activating AhR ligands, that can be extended to bifunctional molecules. The anti-inflammatory properties of these AhR agonists were assessed in interleukin-13 treated keratinocytes. Altogether, the synergistic research in synthetic and computational chemistry integrated with biological studies opens novel avenues toward understanding the biological roles of AhR and the development of targeted therapeutics.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec758042
dc.identifier.issn2374-7951
dc.identifier.urihttps://hdl.handle.net/2445/221704
dc.language.isoeng
dc.publisherAmerican Chemical Society
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1021/acscentsci.5c00194
dc.relation.ispartofACS Central Science, 2025, num.11
dc.relation.urihttps://doi.org/10.1021/acscentsci.5c00194
dc.rightscc by (c) Pau Nadal Rodríguez, et al., 2025
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
dc.subject.classificationQuímica farmacèutica
dc.subject.classificationSíntesi orgànica
dc.subject.classificationCompostos heterocíclics
dc.subject.otherPharmaceutical chemistry
dc.subject.otherOrganic synthesis
dc.subject.otherHeterocyclic compounds
dc.titleA multicomponent reaction-based platform opens new avenues in Aryl Hydrocarbon Receptor modulation
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
892387.pdf
Mida:
7.08 MB
Format:
Adobe Portable Document Format